DrugPatentWatch Database Preview

Lannett Company Profile

LANNETT has one hundred and ninety-six approved drugs.

There is one US patent protecting LANNETT drugs.

There are fifteen patent family members on LANNETT drugs in twelve countries and one hundred and forty-five supplementary protection certificates in twelve countries.

International Patents:	15
US Patents:	1
Tradenames:	143
Ingredients:	133
NDAs:	196
Patent Litigation for Lannett:	See patent lawsuits for Lannett
PTAB Cases with Lannett as petitioner:	See PTAB cases with Lannett as petitioner

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lannett Co Inc	HALOPERIDOL	haloperidol lactate	CONCENTRATE;ORAL	073364-001	Sep 28, 1993	AA	RX	No	No		➤ Sign Up				➤ Sign Up
Lannett Co Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	dexmethylphenidate hydrochloride	TABLET;ORAL	209468-003	Sep 25, 2017	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Lannett	SERPALAN	reserpine	TABLET;ORAL	010124-001	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Lannett Co Inc	PILOCARPINE HYDROCHLORIDE	pilocarpine hydrochloride	TABLET;ORAL	077220-001	Oct 14, 2005	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lannett Co Inc	MYKROX	metolazone	TABLET;ORAL	019532-001	Oct 30, 1987	4,517,179	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Extended-release Capsules	10 mg, 20 mg and 30 mg	➤ Subscribe	2005-05-13
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03
➤ Subscribe	Extended-release Capsules	40 mg	➤ Subscribe	2007-03-15

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2016 00016	Denmark	➤ Sign Up	PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
C/GB01/012	United Kingdom	➤ Sign Up	PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115
C0004	Belgium	➤ Sign Up	PRODUCT NAME: ESTRADIOL, HEMIHYDRATE, NORETHISTERONE, ACETATE; NAT. REGISTRATION NO/DATE: NL 23753 19981210; FIRST REGISTRATION: SE - 14 007 19980306
C/GB97/085	United Kingdom	➤ Sign Up	PRODUCT NAME: LEVOFLOXACIN, OPTIONALLY IN THE FORM OF A HEMIHYDRATE; REGISTERED: UK 13402/0011 19970606; UK 13402/0012 19970606; UK 13402/0013 19970606
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.